Experts say the stock market correction in recent times increases the risk-reward in favour of large-cap stocks.
8 out of 12 sectoral indices closed in red with BSE IT and Healthcare indices losing 0.5%.
Over the past week, the Sensex and the Nifty continued the bull-run
Participants are eagerly waiting for the key macrodata -- IIP and CPI numbers due to be released later today.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
The top gainers on the Sensex are Gail(India), HDFC, Infosys.
Indian loses chance to be research hub as domestic drug companies move R&D overseas.
Asia's falling stocks have triggered an exodus of funds from the region.
The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines
Most Asian markets ended with gains.
Telecom stocks fell after Mukesh Ambani extended Reliance Jio's free offers till March 2017.
The progress of the GST Bill in Parliament is also likely to remain in focus
Financials were the top losers while oil shares also declined amid weak crude oil prices.
Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency
The S&P BSE Sensex plunged 301 points to close at 25,490 and the Nifty50 fell 86 points to end at 7,815.
PSU bank shares were the top gainers on hopes of a rate by the RBI on easing consumer inflation
The Sensex ended below 28,000 for the second straight day at 27,869.
The S&P BSE Sensex ended 46 points lower at 24,824 and Nifty50 settled at 7,555, down by 8 points after hitting intra-day high of 7,600.45.
US stocks rose more than 1% on Tuesday, with the S&P 500 coming less than 2% below its record peak set last month.
Rate sensitive sectors rallied the most led by banks while metals surged on rebound in commodity prices
The biotech company's revenues had fallen to as low as Rs 50 cr.
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
Retracing the journey that brought coffee from Araku Valley in Andhra Pradesh to an upscale caf in the aristocratic district of Le Marais in Paris.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances